Compare RAPP & BLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RAPP | BLND |
|---|---|---|
| Founded | 2022 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 894.7M |
| IPO Year | 2024 | 2021 |
| Metric | RAPP | BLND |
|---|---|---|
| Price | $30.27 | $3.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $47.80 | $4.80 |
| AVG Volume (30 Days) | 368.1K | ★ 4.0M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $167,532,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.81 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 37.61 |
| 52 Week Low | $6.43 | $2.50 |
| 52 Week High | $42.27 | $5.34 |
| Indicator | RAPP | BLND |
|---|---|---|
| Relative Strength Index (RSI) | 62.22 | 49.24 |
| Support Level | $27.81 | $3.18 |
| Resistance Level | $31.00 | $3.40 |
| Average True Range (ATR) | 1.84 | 0.14 |
| MACD | 0.11 | 0.03 |
| Stochastic Oscillator | 83.09 | 48.89 |
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.